Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyInterests: Coronary artery disease; Meta-analysis; Umbrella reviewSpecial Issues and Topics in IMR Press journals
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, ItalyInterests: Oxidative stress; Cardiovascular disease; Antioxidants; Risk factors; Biomarkers; SupplementationSpecial Issues and Topics in IMR Press journals
Dear Colleagues,
Cardiovascular disease remains the leading cause of global mortality and morbidity and represents a major economic burden on health care systems. Smoking is one of the most important modifiable cardiovascular risk factor representing the main preventable cause of morbidity and mortality worldwide. Smoking causes endothelial dysfunction which represents the “primum movens” for the development of cardiovascular atherosclerotic diseases.
Among the different harmful effects of smoking, oxidative stress plays an important role. Smoking may impair oxidative balance by inducing the production of reactive oxygen species (ROS) and by weakening the antioxidant defense systems. Moreover, smoking promotes atherothrombosis by inducing platelet activation. Reactive oxygen species are mostly generated by Nox2, an isoform from NADPH oxidase, that acts as an important regulator of platelet-activation–associated thrombosis.
Indeed, Nox2 has been shown to be associated with several cardiovascular risk factors, such as hypercholesterolemia, metabolic diseases and in patients with peripheral artery disease. Several studies have shown that oxidative stress is involved in the regulation of the pathophysiological processes of cardiovascular diseases.
In this Special Issue, we invite original research as well as review articles discussing the role of smoking and oxidative stress in the setting of cardiovascular disease, to further clarify the role of traditional cigarettes and new modified risk product (heat non burn devices, electronic cigarettes) in these molecular and pathophysiological processes involved in the onset and progression of cardiovascular diseases.
High priority will be given to the following topics:
- molecular mechanisms underlying smoke-mediated damage;
- clinical studies on smoke-associated health derangements;
- meta-analyses or comparative studies on novel smoking products;
- qualitative reviews on smoking-related issues;
- interplay between smoking and inflammation and interaction of smoking with non-pulmonary diseases.
Prof. Dr. Giuseppe Biondi-Zoccai, Dr. Leonardo Schirone and Dr. Mariangela Peruzzi
Guest Editors
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.